Synergism between nifedipine and cyclosporine a on the incorporation of [35S]sulfate into human gingival fibroblast cultures in vitro

Journal of Periodontal Research

Volumn 41, Issue 4, 2006, Pages 316-321

  Flynn, J C ^a   Henderson, J S ^a   Johnson, R B ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Cyclosporine A; Gingival fibroblasts; Gingival overgrowth; Nrfedipine

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; GLYCOSAMINOGLYCAN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; NIFEDIPINE; SULFUR;

ANALYSIS OF VARIANCE; ARTICLE; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; FIBROBLAST; GINGIVA; GINGIVA OVERGROWTH; HUMAN; MALE; METABOLISM; NONPARAMETRIC TEST;

ANALYSIS OF VARIANCE; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; CYCLOSPORINE; DRUG SYNERGISM; FIBROBLASTS; GINGIVA; GINGIVAL OVERGROWTH; GLYCOSAMINOGLYCANS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-1; MALE; NIFEDIPINE; STATISTICS, NONPARAMETRIC; SULFUR RADIOISOTOPES;

EID: 33748552709     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2006.00864.x     Document Type: Article

References (40)

1. Barclay S, Thomason JM, Idle JR, Seymour RA. The incidence and severity of nifedipine-induced gingival overgrowth. J Clin Periodontol 1992;19:311-314.
2. Seymour RA, Jacobs DJ. Cyclosporin and the gingival tissues. J Clin Periodontol 1992;19:1-11.
3. Calne RY, Rolles, K, White DJ et al. Cyclosporin A in clinical organ grafting. Transplant Proc 1981;13:349-358.
4. Stiller CR, Dupre J, Gent M et al. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 1984;223:1362-1367.
5. Nussenblatt RB, Palestine AG, Rook AH, Wacker WB, Seher I, Gery I. Treatment of intraocular inflammatory disease with cyclosporin-A. Lancet 1983;2:235-238.
6. Isenberg D, Snaith M, Al-Klader A et al. Cyclosporin relieves arthralgia, causes angioedema. N Engl J Med 1980;303:754.
7. Thomason JM, Seymour RA, Rice N. The prevalence and severity of Cyclosporin and nifedipine induced gingival overgrowth. J Clin Periodontol 1993;20:37-40.
8. Bartold PM. Regulation of human gingival fibroblast growth and synthetic activity by cyclosporine-A In vitro. J Periodont Res 1989;24:314-321.
9. Hassell TM, Romberg E, Sobhani S, Leskol L, Douglas R. Lymphocyte-mediated effects of cyclosporine on human fibroblasts. Transplant Proc 1988;20:993-1002.
10. McKevitt KM, Irwin CR. Phenotypic differences in growth, matrix synthesis and response to nifedipine between fibroblasts derived from clinically healthy and over-grown gingival tissue. J Oral Pathol Med 1995;24:66-71.
11. Hassell TM, Hefti AF. Drug-induced gingival overgrowth: old problem, new problem. Crit Rev Oral Biol Med 1991;2:103-137.
12. Pernu HE, Knuuttila ML, Huttenen KR, Tilikainen ASK. Drug-induced gingival overgrowth and class II major histocompatibility antigens. Transplantation 1994;57:1811-1813.
13. Narayanan AS, Bartold PM. Biochemistry of periodontal connective tissues and their regeneration: a current perspective. Connect Tissue Res 1996;34:191-201.
14. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 1996;23:165-175.
15. Tipton DA, Fry HR, Dabbous MK. Altered collagen metabolism in nifedipineinduced gingival overgrowth. J Periodont Res 1995;29:401-409.
16. Fujii A, Matsumoto H, Nakao S, Teshigawara H, Akimoto Y. Effect of calcium-channel blockers on cell proliferation, DNA synthesis and collagen synthesis of cultured gingival fibroblasts derived from human nifedipine responders and non-responders. Arch Oral Biol 1994;39:99-104.
17. Mariani G, Calastrini C, Carinci F, Bergamini L, Calastrini F, Stabellini G. Ultrastructural and histochemical features of the ground substance in cyclosporin Ainduced gingival overgrowth. J Periodontol 1996;67:21-27.
18. Martins RC, Werneck CC, Rocha LA, Feres-Filho EJ, Silva LCF. Molecular size distribution analysis of human gingival glycosaminoglycans in cyclosporin- and nifedipine-induced overgrowths. J Periodont Res 2003;38:182-189.
19. Newell J, Irwin CR. Comparative effects of cyclosporin on glycosaminoglycan synthesis by gingival fibroblasts. J Periodontol 1997;68:443-447.
20. Rocha LAG, Martins RCL, Werneck CC, Feres-Filho EJ, Silva LCF. Human gingival glycosaminoglycans in cyclosporineinduced overgrowth. J Periodont Res 2000;35:158-164.
21. 3H-glucosamine by fibroblast populations exposed to cyclosporine. J Periodontol 1994;65:565-567.
22. Wondimu B, Reinholt FP, Modeer T. Stereologic study of cyclosporin A-induced gingival overgrowth in renal transplant patients. Eur J Oral Sci 1995;103:199-206.
23. Radwan-Oczko M, Boratynska M, Klinger M, Zietak M. Risk factors of gingival overgrowth in kidney transplant recipients treated with cyclosporine A. Ann Transplant 2003;8:57-62.
24. O'Valle F, Mesa F, Aneiros J et al. Gingival overgrowth induced by nifedipine and cyclosporin A. Clinical and morphometric study with image analysis. J Clin Periodontol 1995;22:591-597.
25. Sodek J. A new approach to assessing collagen turnover by using a microassay. A highly efficient and rapid turnover of collagen in rat periodontal tissues. Biochem J 1976;160:243-246.
26. Sodek J. A comparison of the rates of synthesis and turnover of collagen and non-collagen proteins in adult rat periodontal tissues and skin using a microassay. Arch Oral Biol 1977;22:655-665.
27. Vardar S, Baylas H, Zihnioglu F, Budundeli N, Emingil G, Attila G. Gingival tissue proteoglycan and chondroitin-4-sulphate levels in cyclosporin A-induced gingival overgrowth and the effects of initial periodontal treatment. J Clin Periodontol 2005;32:634-639.
28. Young RW. The role of the Golgi complex in sulfate metabolism. J Cell Biol 1973;57:175-189.
29. Morisaki I, Fukui N, Fujimori Y, Murakami J, Dakoku H, Amano A. Effects of combined oral treatments with cyclosporine A and nifedipine or diltiazem on drug-induced gingival overgrowth in rats. J Perindontol 2000;71:438-443.
30. Chiu H-C, Fu E, Chiang C-Y, Liu D. Does nifedipine aggravate cyclosporin-induced gingival overgrowth? An experiment in rats. J Periodontol 2001;72:532-537.
31. Henderson JS, Flynn JC, Tucci MA, Tsao AK, Zebrowski EJ. Site-specific variations in metabolism by human fibroblasts exposed to nifedipine in vitro. J Oral Pathol Med 1997;26:6-10.
32. Nishikawa S, Tada H, Hamasaki A et al. Nifedipine-induced gingival hyperplasia: a clinical and in vitro study. J Periodontol 1991;62:30-35.
33. Salo T, Oikarinen KS, Oikarinen AI. Effect of phenytoin and nifedipine on collagen gene expression in human gingival fibroblasts. J Oral Pathol Med 1990;19:40-407.
34. Schincaglia GP, Forniti F, Cavallini R, Piva R, Calura G, del Senno L. Cyclosporin-A increases type I procollagen production and mRNA level in human gingival fibroblasts in vitro. J Oral Pathol Med 1992;21:181-185.
35. Mariani G, Calastrini C, Carinci F, Marzola R, Calura G. Ultrastructural features of cyclosporine A-induced gingival hyperplasia. J Periodontol 1993;64:1092-1097.
36. Spoildorio LC, Spoildorio DM, Neves KA et al. Morphological evaluation of combined effects of cyclosporin and nifedipine on gingival overgrowth in rats. J Periodont Res 2002;37:192-195.
37. Johnson RB. Synergistic enhancement of collagenous protein synthesis by human gingival fibroblasts exposed to nifedipine and TNF-alpha in vitro. J Oral Pathol Med 2002;32:408-413.
38. Johnson RB, Zebrowski EJ, Dai X. Synergistic enhancement of collagenous protein synthesis by human gingival fibroblasts exposed to nifedipine and interleukin-1-beta in vitro. J Oral Pathol Med 2000;29:8-12.
39. Bullon P, Machuca G, Martinez-Sahuquillo A et al. Evaluation of gingival and periodontal conditions following causal periodontal treatment in patients treated with nifedipine and diltiazem. J Clin Periodontol 1996;23:649-657.
40. Somacarrera ML, Lucas M, Scully C, Barrios C. Effectiveness of periodontal treatments on cyclosporine-induced gingival overgrowth in transplant patients. Br Dent J 1997;183:89-94.